Tue Oct 07 2025
This episode of *On The Pen* dives into three major developments shaping obesity care: Fractyl Health’s groundbreaking GLP-1 + GIP gene therapy, Dr. Mehmet Oz’s hints about potential Medicare coverage for GLP-1s, and the federal court ruling on retatrutide that could redefine compounded access. Together, these stories reveal how science, policy, and regulation are colliding to decide the future of obesity treatment.
Get AI-powered summaries and transcripts for any meeting, phone call, or podcast.
Available on iOS, Android, Mac, and Windows
No transcript available.
